[1]
|
M. H. Shiu, D. Schottenfeld, B. Maclean and J. G. Fortner, “Adverse Effect of Pregnancy on Melanoma: A Reappraisal,” Cancer, Vol. 37, No. 1, 1976, pp. 181-187.
|
[2]
|
F. J. Collinson, T. K. Lam, W. M. Bruijn, J. H. M. De Wilt, M. Lamont. J. K. Thompson and R. F. Kefford, “Longterm Survival and Occasional Regression of Distat Melanoma M, Etastases after Adrenal Metastectomy,” Annals of Surgical Oncology, Vol. 15, No. 6, 2008, pp. 1741-1749. doi:10.1245/s10434-008-9836-y
|
[3]
|
M. D. Bregman, E. Peters, D. Sander, F. L. Meyskens Jr., Dexamethsone, “Prostaglandin A and Retinoic Acid Modulation of Murine and Human Melanoma Cells Grown in Soft Agar,” Journal of the National Cancer Institute, Vol. 71, No. 5, 1983, pp. 927-932.
|
[4]
|
M. T. Ramirez, A. Chow, D. Hirschhorn Cymerman, T. H. Terwey, A. A. Hochma, S. Lu, R. C. Miles, S. Sakaguchi, A. N. Houghton and M. R. van den Brink, “Glucocorti- copid-Induced TNF Receptor Family Related Gene Acti- vation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immu- nity,” The Journal of Immunology, Vol. 176, No. 11, 2006, pp. 6434-6442.
|
[5]
|
M. Banci, J. M. Metselaar, R. M. Schiffelers and G. Storm, “Antitumor Activity of Liposomal Prednisolone Phosphate Depends on the Presence of Functional Tumor-Associated Macrophages in Tumor Tissue,” Neoplasia, Vol. 10, No. 2, 2008, pp. 108-117.
doi:10.1593/neo.07913
|
[6]
|
L. A. Smets, B. Bout and M. Brouwer, “A Tulp Cytotoxic Effect of Dexamethsone Restricted to Noncycling, Early G1 Phase Cells of L1210 Leukemia,” Journal of Cellular Physiology, Vol. 116, No. 3, 1983, pp. 397-403.
doi:10.1002/jcp.1041160318
|
[7]
|
K. Liao, P. B. Dent and P. B. McCulloch, “Characterization of Human Malignant Melanoma Cell Lines. I. Morphology and Growth Characteristics in Culture,” Journal of the National Cancer Institute, Vol. 54, No. 5, 1975, pp. 1037-1044.
|
[8]
|
A. Tulp, J. G. Collard, A. A. M. Hart and J. A. Aten, “A New Unit Gravity Sedimentation Chamber,” Analytical Biochemistry, Vol. 105, No. 1, 1980, pp. 246-256.
doi:10.1016/0003-2697(80)90452-2
|
[9]
|
A. M. Osman, O. A. Nasseir and N. R. Ismail, “Potential Mechanism for the Effects of Dexamethasone on Growth of Human Melanoma Cells in Vitro,” Health, Vol. 2, No. 8, 2010, pp. 857-886. doi:10.4236/health.2010.28129
|
[10]
|
J. R. Whittak, “Changes in Melanogenesis during the Dedifferentiation of Chick Retinal Pigment Cells in Cell Cultures,” Developmental Biology, Vol. 8, No. 1, 1963, pp. 99-127. doi:10.1016/0012-1606(63)90028-9
|
[11]
|
W. H. McCarthy, A. L. Black and G. W. Milton, “Melanoma in New South Wales: An Epidemiologic Survey, 1970-1976,” Cancer, Vol. 46, No. 2, 1980, pp. 427-432.
doi:10.1002/1097-0142(19800715)46:2<427::AID-CNCR2820460237>3.0.CO;2-E
|
[12]
|
L. Nathanson, “Epidemiologic and Etiologic Considera- tions in Malignant Melanoma,” In: J. J. Costanzi, Ed., Cancer Treatment and Research, Martinus Nijhoff, the Huige, Vol. 9, 1983, pp. 1-27.
doi:10.1146/annurev.genet.38.072902.092717
|
[13]
|
R. L. Comis, “DTIC (NSC-45388) in Malignant Melanoma: A Perspective,” Cancer Treat Rep, Vol. 60, No. 2, 1976, pp. 165-176.
|
[14]
|
J. J. Costanzi, “The Chemotherapy of Malignant Melanoma,” In: J. J. Costanzi, Ed., Cancer Treatment and Research, Martinus Nijhoff, the Huige, Vol. 9, 1983, pp. 259-274.
|
[15]
|
A. Ristic-Fira, M. Vujcic, M. Krstic-Demonacos, D. Kanazir, “Identification and Characterization of Glucocorticoid Receptors in B16 Mouse Melanoma Cells,” Endocrine Regulations, Vol. 33, No. 3, 1999, pp. 109-115.
|
[16]
|
R. A. Ramos,Y. Nishio, A. C. Maiyar, K. E. Simon ,C. C. Ridder, Y. Ge and G. L. Firestone, “Glucocorticoid- Sti- mulated CCAAT/Enhancer-Binding Protein Alpha Expression is Required for Steroid-Induced G1 Cell Cycle Arrest of Minimal-Deviation Rat Hepatoma Cells,” Molecular and Cellular Biology, Vol. 16, No. 10, October 1996, pp. 5288-5301.
|
[17]
|
J. K. Chang, C. J. Li , H. J. Liao , C. K. Wang, G. J. Wang and M. L. Ho, “Anti-Inflammatory Drugs Suppress Proliferation and Induce Apoptosis through Altering Expressions of Cell Cycle Regulators and Pro-Apoptotic Factors in Cultured Human Osteoblasts,” Toxicology, Vol. 258, No. 2-3, 28 April 2009, pp. 148-156.
|
[18]
|
Han-M., Koo, M. VanBrocklin, M. J. McWilliams, S. H. Leppla, N. S. Duesbery and G. F. Vande Woude, “Apo- ptosis and Melanogenesis in Human Melanoma Cells Induced by Anthrax Lethal Factor Inactivation of Mitogen-Activated Protein Kinase,” PNAS, Vol. 99, No. 5, 2002, pp. 3052-3057. doi:10.1073/pnas.052707699
|